Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


PharmaZen boosts 2013 earnings

PharmaZen boosts 2013 earnings on calcium pick up and new technology

By Suze Metherell

April 4 (BusinessDesk) – Biotechnology company PharmaZen says full year pretax earnings rose 38 percent as it entered the retail market with its calcium supplement, StimuCal.

PharmaZen posted a $739,114 profit in calendar 2013, up from $537,108 in 2012, the Dunedin-based company said in a statement. Sales lifted 4.7 percent to $7 million.

Last year PharmaZen launched and patented StimuCal, the first time it had entered the retail market with a branded product. It developed the slow release calcium supplement after a link between spikes in calcium serum and heart attacks was established, which had impacted the calcium market and weakened its first-half earnings.

“While this is causing some short term pain, it is something we have seen coming for the last two to three years and have been investing heavily in product development to find a solution,” chief executive Craig McIntosh said at the time.

PharmaZen said it is investing in product and capability to drive future earnings. The company expanded its manufacturing with a fluidized powder blender allowing precise measurements and this year expects to install a new spray dryer to complement its traditional freeze and vacuum drying capabilities.

Its trading division Waitaki Biosciences, the nutraceuticals and dietary supplements business, exports to Australia, the US, Asia and Europe. PharmaZen said 2013 had been a “challenging environment for exporters” due to the high kiwi dollar.

“There is no doubt that exchange rates and margins will again prove challenging for 2014,” McIntosh said. “Through diversification of product range and increased capabilities, PharmaZen is well positioned.”

The company’s shares, which trade on the Unlisted Exchange, were unchanged at 60 cents and doubled last year.

(BusinessDesk)


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Half Full: Dairy Payouts Steady, Cash Will Be Tight

Industry body DairyNZ is advising farmers to focus on strong cashflow management as they look ahead to the 2015-16 season following Fonterra's half-year results announcement today. More>>

ALSO:

First Union: Cotton On Plans To Use “Tea Break” Law

“The Prime Minister reassured New Zealanders that ‘post the passing of this law, will you all of a sudden find thousands of workers who are denied having a tea break? The answer is absolutely not’... Cotton On is proposing to remove tea and meal breaks for workers in its safety sensitive distribution centre. How long before other major chains try and follow suit?” More>>

ALSO:

Scoop Business: NZ-Korea FTA Signed Amid Spying, Lost Sovereignty Claims

A long-awaited free trade agreement between New Zealand and South Korea has been signed in Seoul by Prime Minister John Key and the Korean president, Park Geun-hye. More>>

ALSO:

PM Visit: NZ And Viet Nam Agree Ambitious Trade Target

New Zealand and Viet Nam have agreed an ambitious target of doubling two-way goods and service trade to around $2.2 billion by 2020, Prime Minister John Key has announced. More>>

ALSO:

Scoop Business: NZ Economy Grows 0.8% In Fourth Quarter

The New Zealand economy expanded in the fourth quarter as tourists drove growth in retailing and accommodation, and property sales increased demand for real estate services. More>>

ALSO:

Scoop Business: RBNZ’s Wheeler Keeps OCR On Hold, No Rate Hikes Ahead

The Reserve Bank has removed the prospect of future interest rate hikes from its forecast horizon as a strong kiwi dollar and cheap oil hold down inflation, and the central bank ponders whether to lower its assessment of where “neutral” interest rates should be. The kiwi dollar gained. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news